Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Fibromyalgia Pain
NCT03029845Phase 1Terminated
- Sponsor
- University of Utah
- Start
- Jan 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of propranolol in fibromyalgia (FM) (3 arms), sponsored by University of Utah. Primary endpoint: Fibromyalgia Impact Questionnaire - Revised at 2 weeks. Started Jan 2017; status: terminated.
02
Drugs
propranolol
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT03029845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03029845.